Form 4 for TCRX TScan Therapeutics, Inc.
Accepted 2021-09-27 00:00:00 ET · period of report 2021-09-23 · accession 0000899243-21-037802 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-27 | 2021-09-23 | TCRX | ZDRAVESKI ZORAN | CLO | P - Purchase | $7.48 | +4,716 | 4,716 | New | +$35.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Voting Common Stock | 2021-09-23 | P | A | 4,716 | $7.48 | 4,716 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $7.43 to $7.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. |